HCPCS Level II drug code
J2248 — Injection, micafungin sodium, 1 mg
In short
J2248 is the HCPCS Level II code for injection, micafungin sodium, 1 mg. CMS assigns NDCs for Micafungin, Micafungin Sodium and Mycamine to it. One billing unit is 1 mg. The Medicare Part B payment limit is $0.203 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, micafungin sodium, 1 mg
- Short descriptor
- Micafungin sodium injection
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2016
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J2248
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 37 NDCs to J2248 for Micafungin, Micafungin Sodium and Mycamine. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Micafungin | 00143-9361-01 | Hikma Pharmaceuticals USA Inc. | 1 | 50 |
| Micafungin | 00143-9362-01 | Hikma Pharmaceuticals USA Inc. | 1 | 100 |
| Micafungin | 25021-0190-10 | Sagent Pharmaceuticals | 1 | 50 |
| Micafungin | 25021-0190-11 | Sagent Pharmaceuticals | 10 × 1 | 500 |
| Micafungin | 25021-0190-12 | Sagent Pharmaceuticals | 20 × 1 | 1,000 |
| Micafungin | 25021-0191-10 | Sagent Pharmaceuticals | 1 | 100 |
| Micafungin | 25021-0191-11 | Sagent Pharmaceuticals | 10 × 1 | 1,000 |
| Micafungin | 25021-0191-12 | Sagent Pharmaceuticals | 20 × 1 | 2,000 |
| Micafungin | 60505-6119-05 | Apotex Corp | 10 × 1 | 500 |
| Micafungin | 60505-6120-06 | Apotex Corp | 10 × 1 | 1,000 |
| Micafungin | 63323-0729-12 | FreseniUS Kabi USA, LLC | 10 × 1 | 1,000 |
| Micafungin | 68462-0771-01 | Glenmark Pharmaceuticals Inc., USA | 1 | 50 |
| Micafungin | 68462-0771-10 | Glenmark Pharmaceuticals Inc., USA | 10 × 1 | 500 |
| Micafungin | 68462-0772-01 | Glenmark Pharmaceuticals Inc., USA | 1 | 100 |
| Micafungin | 68462-0772-10 | Glenmark Pharmaceuticals Inc., USA | 10 × 1 | 1,000 |
| Micafungin | 70377-0075-91 | Biocon Pharma Inc | 10 × 1 | 500 |
| Micafungin | 70377-0076-91 | Biocon Pharma Inc | 10 × 1 | 1,000 |
| Micafungin | 70594-0036-01 | Xellia Pharmaceuticals USA, LLC. | 1 | 50 |
| Micafungin | 70594-0037-01 | Xellia Pharmaceuticals USA, LLC. | 1 | 100 |
| Micafungin | 70710-1724-06 | Zydus Pharmaceuticals (USA) Inc. | 10 × 1 | 500 |
| Micafungin | 70710-1725-01 | Zydus Pharmaceuticals (USA) Inc. | 1 | 100 |
| Micafungin | 70710-1725-06 | Zydus Pharmaceuticals (USA) Inc. | 10 × 1 | 1,000 |
| Micafungin | 71288-0028-12 | Meitheal Pharmaceuticals Inc. | 1 | 50 |
| Micafungin | 71288-0029-12 | Meitheal Pharmaceuticals Inc. | 1 | 100 |
| Micafungin | 72572-0427-01 | Civica, Inc. | 1 | 100 |
| Micafungin Sodium | 16714-0164-10 | Northstar RxLLC | 10 × 1 | 500 |
| Micafungin Sodium | 16714-0301-10 | Northstar RxLLC | 10 × 1 | 1,000 |
| Micafungin Sodium | 42658-0022-01 | Hisun Pharmaceuticals Usa, Inc. | 1 | 50 |
| Micafungin Sodium | 42658-0022-02 | Hisun Pharmaceuticals Usa, Inc. | 10 × 1 | 500 |
| Micafungin Sodium | 42658-0023-01 | Hisun Pharmaceuticals Usa, Inc. | 1 | 100 |
| Micafungin Sodium | 42658-0023-02 | Hisun Pharmaceuticals Usa, Inc. | 10 × 1 | 1,000 |
| Micafungin Sodium | 71288-0028-11 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 500 |
| Micafungin Sodium | 71288-0029-11 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 1,000 |
| Mycamine | 00469-3211-10 | Astellas Pharma US, Inc. | 10 × 1 | 1,000 |
| Mycamine | 00469-3250-10 | Astellas Pharma US, Inc. | 10 × 1 | 500 |
| Mycamine | 63323-0728-10 | FreseniUS Kabi USA, LLC | 10 × 1 | 500 |
| Mycamine | 63323-0729-10 | FreseniUS Kabi USA, LLC | 10 × 1 | 1,000 |
J2248: common questions
- Is J2248 a CPT code?
- No. J2248 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J2248?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 37 NDCs under J2248, for Micafungin, Micafungin Sodium and Mycamine. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J2248?
- $0.203 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J2248?
- One unit of J2248 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.